Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) EPS (Weighted Average and Diluted) (2020 - 2025)

Agilon Health (AGL) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$0.46 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 76.92% year-over-year to -$0.46, compared with a TTM value of -$0.98 through Dec 2025, down 60.66%, and an annual FY2025 reading of -$0.98, down 60.66% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.46 for Q4 2025 at Agilon Health, down from -$0.27 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.03 in Q1 2025 and bottomed at -$0.46 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.11, with a median of -$0.05 recorded in 2022.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 1876.99% in 2023, while the deepest fall reached 32552.32% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.06 in 2021, then skyrocketed by 97.84% to -$0.0 in 2022, then crashed by 32552.32% to -$0.4 in 2023, then soared by 35.0% to -$0.26 in 2024, then crashed by 76.92% to -$0.46 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for AGL at -$0.46 in Q4 2025, -$0.27 in Q3 2025, and -$0.25 in Q2 2025.